Extended retreatment with brentuximab vedotin (SGN-35) maintains complete remission in patient with recurrent systemic anaplastic large-cell lymphoma

Kelley V. Foyil; Dana A. Kennedy; Laurie E. Grove; Nancy L. Bartlett; Amanda F. Cashen

doi:10.3109/10428194.2011.614706

Extended retreatment with brentuximab vedotin (SGN-35) maintains complete remission in patient with recurrent systemic anaplastic large-cell lymphoma

Kelley V. Foyil, Dana A. Kennedy, Laurie E. Grove, Nancy L. Bartlett, Amanda F. Cashen

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	506-507
Number of pages	2
Journal	Leukemia and Lymphoma
Volume	53
Issue number	3
DOIs	https://doi.org/10.3109/10428194.2011.614706
State	Published - Mar 2012

Access to Document

10.3109/10428194.2011.614706

Cite this

@article{59ffb4f7973947d0974afbd2b08104be,

title = "Extended retreatment with brentuximab vedotin (SGN-35) maintains complete remission in patient with recurrent systemic anaplastic large-cell lymphoma",

author = "Foyil, {Kelley V.} and Kennedy, {Dana A.} and Grove, {Laurie E.} and Bartlett, {Nancy L.} and Cashen, {Amanda F.}",

year = "2012",

month = mar,

doi = "10.3109/10428194.2011.614706",

language = "English",

volume = "53",

pages = "506--507",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

number = "3",

}

TY - JOUR

T1 - Extended retreatment with brentuximab vedotin (SGN-35) maintains complete remission in patient with recurrent systemic anaplastic large-cell lymphoma

AU - Foyil, Kelley V.

AU - Kennedy, Dana A.

AU - Grove, Laurie E.

AU - Bartlett, Nancy L.

AU - Cashen, Amanda F.

PY - 2012/3

Y1 - 2012/3

UR - http://www.scopus.com/inward/record.url?scp=84857587738&partnerID=8YFLogxK

U2 - 10.3109/10428194.2011.614706

DO - 10.3109/10428194.2011.614706

M3 - Letter

C2 - 21867368

AN - SCOPUS:84857587738

SN - 1042-8194

VL - 53

SP - 506

EP - 507

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 3

ER -

Extended retreatment with brentuximab vedotin (SGN-35) maintains complete remission in patient with recurrent systemic anaplastic large-cell lymphoma

Access to Document

Other files and links

Cite this